Скачать или смотреть Can Big Pharma Hijack Cannabis?

Cannabis helped real patients before corporations noticed. Now boardrooms are circling. In this episode of The Dr. Joudeh Effect, Dr. Ramsey breaks down how Big Pharma is moving to control medical cannabis—through acquisitions, patent fences, and D.C. lobbying—and what that could mean for price, access, and patient choice.

What you’ll learn:
• The science behind whole‑plant medicine (CBD + THC + terpenes) and why it can outperform single‑molecule drugs
• How pharma’s M&A and patents aim to corner cannabinoid therapies
• Why scheduling and federal rules can lock out dispensary‑grade, full‑spectrum options
• The patient impact: higher costs, fewer choices, more gatekeeping—unless we push for evidence‑based, patient‑first policy

Takeaway: Medicine should follow outcomes, not quarterly earnings. If cannabis works for chronic pain, sleep, PTSD, or seizures, patients deserve affordable, transparent access—without corporate choke points.

👉 Subscribe for more straight‑talk on medicine, policy, and power.
💬 Drop your questions or stories below—your voice matters.

#Cannabis #MedicalCannabis #BigPharma #CBD #THC #EntourageEffect #HealthPolicy #DrJoudehEffect